Clinical trial
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients…
NCT00003816 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00003816 |
|---|---|
| Title | Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer |
| Official title | Allogeneic Blood or Marrow Transplantation for Hematologic Malignancy and Aplastic Anemia |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Nonmalignant Neoplasm, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor |
| Intervention type | Biological, Drug, Radiation |
| Interventions | anti-thymocyte globulin, busulfan, carboplatin, cyclophosphamide, etoposide, fludarabine phosphate, melphalan, thiotepa, total-body irradiation |
| Enrollment | 361 |
| Start date | Oct 19, 1998 |
| Primary completion | Jul 12, 2019 |
| Completion | Jul 12, 2019 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 13, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: